Skip to main content
CVE-2025-10222VulnerabilityPublished Updated

CVE-2025-10222: AxxonSoft AxxonOne C-Werk · Information Exposure

Affects AxxonSoft AxxonOne C-WerkSource CVE Database V5

0

Not known to be exploited · CVSS 3.3 Low.

Data as of 26 Oct 2026, 06:26 UTC

CVSS 3.1 base score
3.3Low
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 2% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 10 Sep 2025

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2026-10-26.

What to do

Affected software

ProductAffectedFixed in
AxxonSoft AxxonOne C-WerkAffected
  • =2.0.0
Fixed in–

AI-suggested

To mitigate this vulnerability, European organizations should implement strict access controls on diagnostic export files generated by the AxxonOne C-Werk VMS. This includes setting file system permissions to restrict read access only to trusted administrators and system processes. Monitoring and auditing local user activity around the creation and access of diagnostic files can help detect unauthorized attempts to read sensitive information. Organizations should also consider disabling or limiting the use of the built-in troubleshooting tool on production systems if not required. Applying the principle of least privilege to local user accounts reduces the risk of exploitation. Since no patches are currently linked, organizations should engage with AxxonSoft for updates or advisories. Additionally, network segmentation and endpoint protection can help prevent attackers from gaining local access in the first place. Finally, educating staff about the risks of local information disclosure and enforcing strong physical and logical access controls will further reduce exposure.

Description

Exposure of Sensitive Information to an Unauthorized Actor (CWE-200) in the diagnostic dump component in AxxonSoft Axxon One VMS (C-Werk) 2.0.0 through 2.0.1 on Windows allows a local attacker to obtain licensing-related information such as timestamps, license states, and registry values via reading diagnostic export files created by the built-in troubleshooting tool.

References

Community reviews

Loading reviews…